A systematic approach to the evaluation and characterization of treatment resistance in
schizophrenia has become increasingly important since the introduction of the second …

These guidelines for the biological treatment of schizophrenia were developed by an
international Task Force of the World Federation of Societies of Biological Psychiatry …

Objective: To review the literature on efficacy and risks of combining antipsychotics (atypical
with atypical or conventional) and suggest a rationale and strategies for future clinical trials …

OBJECTIVE: Since use of multiple drugs to treat psychiatric patients is increasing, and
research on this practice is rare, the authors carried out a retrospective case-control study of …

Objective: To determine the prevalence, trends, and factors associated with antipsychotic
polypharmacy categorized according to type of antipsychotic and duration of use and to …

The atypical antipsychotics risperidone, olanzapine, quetiapine, ziprasidone, and
aripiprazole have become first-line treatment for schizophrenia because they reduce the …

This report summarizes the recommendations from a consensus meeting that focused on
specific questions regarding the pharmacotherapy of schizophrenia. The issues were …

Most research literature concerning pharmacological treatments reports results from
controlled clinical trials, which provide data critical to assess the efficacy of new treatments …

Background: Polypharmacy in patients with schizophrenia is a common practice with little
basis in well-controlled studies. The objective of this report is to describe the changes in …

Die Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN)
arbeitet intensiv an der Entwicklung des konzeptuellen und instrumentellen Rüstzeugs für …